2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Myeloid
2
Classical hematology
2
Conditions
Colorectal Neoplasms
28
Neoplasms
13
Colonic Neoplasms
12
Breast Neoplasms
12
Prostatic Neoplasms
9
Polycythemia Vera
9
Venous Thromboembolism
8
Multiple Myeloma
8
Recurrence
6
Carcinoma, Non-Small-Cell Lung
6
Rectal Neoplasms
5
Thrombocythemia, Essential
4
Ovarian Neoplasms
4
Neoplasms, Plasma Cell
4
Neoplasm Metastasis
4
Myeloproliferative Disorders
4
Esophageal Neoplasms
4
Cardiovascular Diseases
4
Barrett Esophagus
4
Stomach Neoplasms
3
Precancerous Conditions
3
Melanoma
3
Lung Neoplasms
3
Gastrointestinal Neoplasms
3
Adenomatous Polyps
3
Adenoma
3
Tobacco Use Disorder
2
Thrombosis
2
Thromboembolism
2
Smoking Cessation
2
Interventions
Cyclophosphamide
62
fludarabine phosphate
55
Peripheral Blood Stem Cell Transplantation
44
ruxolitinib
41
Tacrolimus
41
Busulfan
40
Mycophenolic Acid
36
Whole-Body Irradiation
32
Antilymphocyte Serum
29
Methotrexate
27
Cyclosporine
27
fludarabine
24
Melphalan
19
Filgrastim
19
Radiotherapy
15
Methylprednisolone
13
thymoglobulin
12
Stem Cell Transplantation
12
Etoposide
12
Cord Blood Stem Cell Transplantation
12
Azacitidine
12
Sirolimus
11
Flow Cytometry
10
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
10
Psychiatric Rehabilitation
9
Decitabine
9
Specimen Handling
8
Prednisone
8
Cytarabine
8
navitoclax
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Primary Myelofibrosis
×
Aspirin
×
Clear all
NCT05198960
2026-03-20
AVAJAK
University Hospital, Brest
Phase 3
Recruiting
1,308 enrolled
NCT04243122
2024-05-29
AIRPORT-MPN
Ottawa Hospital Research Institute
Phase 2
Completed
44 enrolled